Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial. (2019)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1186/s13063-019-3423-3
PubMed Identifier: 31307503
Publication URI: http://europepmc.org/abstract/MED/31307503
Type: Journal Article/Review
Volume: 20
Parent Publication: Trials
Issue: 1
ISSN: 1745-6215